HLB Life Science Co. Ltd (067630) — Long-term Investment Intensity
HLB Life Science Co. Ltd (067630) has a Long-term Investment Intensity of 27.1% as of September 2019. Long-term investments of ₩96.14 Billion represent 27.1% of total assets of ₩354.61 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check cash flow reinvestment rate of HLB Life Science Co. Ltd to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
HLB Life Science Co. Ltd Long-term Investment Intensity (2014–2018)
This chart shows how HLB Life Science Co. Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2014 to 2018. As of September 2019, the intensity stands at 27.1%, reflecting long-term investments of ₩96.14 Billion against total assets of ₩354.61 Billion KRW. Explore 067630 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for HLB Life Science Co. Ltd (2014–2018)
The table below presents the year-by-year Long-term Investment Intensity for HLB Life Science Co. Ltd from 2014 to 2018, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is HLB Life Science Co. Ltd worth.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 5.3% | ₩20.61 Billion | ₩386.26 Billion | ▼ -13.0 pp |
| 2017 | 18.3% | ₩18.12 Billion | ₩99.02 Billion | ▼ -3.8 pp |
| 2016 | 22.1% | ₩18.30 Billion | ₩82.68 Billion | ▲ +16.1 pp |
| 2015 | 6.0% | ₩2.58 Billion | ₩42.70 Billion | ▲ +0.3 pp |
| 2014 | 5.7% | ₩1.91 Billion | ₩33.39 Billion | — |